Why Is Arcutis Biotherapeutics ($ARQT) Stock Down -17.83% Today?
Shares plunged 17.83% to $27.98, down from the prior session's close of $34.05.
Primary catalyst: Third-quarter earnings missed Wall Street's bottom-line estimate, with EPS of $0.06 versus a consensus of $0.18.
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly